Diag2Tec – Preclinical CRO in Multiple Myeloma, Lymphoma, Leukemia
  • Home
  • Our Expertise
    • Multiple Myeloma
    • Hematological Cancer Cell Lines from Patients
    • Primary Samples from Hematological Malignancies
    • In Vitro Model of Human Plasma Cell Differentiation
    • Flow Cytometry
    • NGS – Biomarkers – New Therapeutic Targets Identification
  • Preclinical Services
    • In vitro Drug Testing
    • Immunotherapies : Assays and Analyses
    • Prognosis and Predictive Biomarkers
  • About us
    • Team & History
    • Prospects and Partners
    • ISO 9001: 2015 Certification
  • Press & Events
    • List of Publications and Patents
    • Meet our team
  • Contact
    • Contact us
    • Opportunities
logo

Sitemap

Home → Diag2Tec – Preclinical CRO in MM, Lymphoma, Leukemia → Sitemap

Site Feeds

  • Main RSS Feed
  • Comments RSS Feed

Pages

  • About us
    • ISO 9001: 2015 Certification
    • Prospects and Partners
    • Team & History
  • ChimioFx : Multiple Myeloma Precision Medicine tests
  • Contact & Job opportunities
  • Diag2Tec – Preclinical CRO in MM, Lymphoma, Leukemia
    • Sitemap
  • Legal Notice
  • Meet our team
  • Our Expertise
    • Flow Cytometry
    • Hematological Cancer Cell Lines from Patients
    • In Vitro Model of Human Plasma Cell Differentiation
    • Multiple Myeloma
    • NGS – Biomarkers – New Therapeutic Targets Identification
    • Primary Samples from Hematological Malignancies
  • Our News
  • Preclinical Services
    • Immunotherapies : Assays and Analyses
    • In Vitro Drug Testing
    • Prognosis and Predictive Biomarkers

Categories

  • News
  • Publications

Monthly Archives

  • February 2019
  • November 2018
  • May 2018
  • February 2018
  • December 2017
  • June 2017
  • July 2016
  • May 2016
  • November 2015
  • June 2015
  • February 2013

Tags

  • Publications

All Articles

  1. The publication’s team in the front cover of Theranostics journal
    5-Feb-19 • Angélique Bruyer • 0 Comment
  2. Diag2Tec s’attaque au myélome multiple
    14-Nov-18 • admin • 0 Comment
  3. Diag2Tec présente son pitch aux investisseurs lors du salon Occitanie Invest
    10-Nov-18 • admin • 0 Comment
  4. List of Publications and Patents
    5-Nov-18 • admin • 0 Comment
  5. BioPharlAnalyses
    28-May-18 • admin • 0 Comment
  6. Montpellier’s BIC
    2-Feb-18 • admin • 0 Comment
  7. 2017 Annual Congress of American Society of Hematology
    9-Dec-17 • admin • 0 Comment
  8. Midi Libre Newspaper
    28-Jun-17 • admin • 0 Comment
  9. Diag2Tec lauréat du concours i-Lab
    28-Jul-16 • admin • 0 Comment
  10. i-Lab 2016 : Catégorie Création-développement
    25-Jul-16 • admin • 0 Comment
  11. Diag2Tec visit in Florida
    23-May-16 • admin • 0 Comment
  12. Interview of Jerome Moreaux, Diag2Tec’s CSO
    4-Nov-15 • admin • 0 Comment
  13. Diag2Tec soutenue par Crealia
    18-Jun-15 • admin • 0 Comment
  14. Jérôme Moreaux Lauréat Chercheur D’avenir 2013
    5-Feb-13 • Angélique Bruyer • 0 Comment

Diag2Tec’s Headquarters

Immeuble le Stratège
1095 rue Henri Becquerel
34000 Montpellier FRANCE

Diag2Tec’s Laboratories

CHU St Eloi, Dpt Hematology Biology
80 Av Augustin Fliche
34295 Montpellier FRANCE
Diag2Tec logo

  Contact us

Documentation

Services brochure
Publications and Patents
ISO 9001 Certification

Preclinical Services

In vitro Drug Testing
Immunotherapies : Assays and Analysis
Prognosis and Predictive Biomarkers
© Diag2Tec all rights reserved - Legal Notice
Back to Top